169 related articles for article (PubMed ID: 7587130)
1. Exploiting multidrug resistance to treat cancer.
Gottesman MM; Ambudkar SV; Ni B; Aran JM; Sugimoto Y; Cardarelli CO; Pastan I
Cold Spring Harb Symp Quant Biol; 1994; 59():677-83. PubMed ID: 7587130
[No Abstract] [Full Text] [Related]
2. Therapeutic strategies involving the multidrug resistance phenotype: the MDR1 gene as target, chemoprotectant, and selectable marker in gene therapy.
Aran JM; Pastan I; Gottesman MM
Adv Pharmacol; 1999; 46():1-42. PubMed ID: 10332500
[No Abstract] [Full Text] [Related]
3. Construction of MDR1 vectors for gene therapy.
Sugimoto Y; Gottesman MM; Pastan I; Tsuruo T
Methods Enzymol; 1998; 292():523-37. PubMed ID: 9711580
[No Abstract] [Full Text] [Related]
4. Microbial multidrug-resistance ABC transporters.
Ouellette M; Légaré D; Papadopoulou B
Trends Microbiol; 1994 Oct; 2(10):407-11. PubMed ID: 7850210
[TBL] [Abstract][Full Text] [Related]
5. Role of gene amplification in drug resistance.
Schoenlein PV
Cancer Treat Res; 1994; 73():167-200. PubMed ID: 7710905
[No Abstract] [Full Text] [Related]
6. Retroviral transfer of multidrug transporter to murine hematopoietic stem cells.
Licht T; Gottesman MM; Pastan I
Methods Enzymol; 1998; 292():546-57. PubMed ID: 9711582
[No Abstract] [Full Text] [Related]
7. Multidrug resistance in lung cancer.
Broxterman HJ; Versantvoort CH; Linn SC
Cancer Treat Res; 1995; 72():193-222. PubMed ID: 7702987
[No Abstract] [Full Text] [Related]
8. Retroviral transfer of human MDR1 gene into human T lymphocytes.
Lee CG; Pastan I; Gottesman MM
Methods Enzymol; 1998; 292():557-72. PubMed ID: 9711583
[No Abstract] [Full Text] [Related]
9. Multidrug resistance: genes, polymorphisms, biologic effects, reversal and treatment in cancer chemotherapy.
Aragon-Ching JB
Anticancer Agents Med Chem; 2010 Oct; 10(8):582. PubMed ID: 21244347
[No Abstract] [Full Text] [Related]
10. Multidrug resistance in cancer chemotherapy.
Patel NH; Rothenberg ML
Invest New Drugs; 1994; 12(1):1-13. PubMed ID: 7960599
[TBL] [Abstract][Full Text] [Related]
11. Construction of MDR1 adeno-associated virus vectors for gene therapy.
Baudard M
Methods Enzymol; 1998; 292():538-45. PubMed ID: 9711581
[No Abstract] [Full Text] [Related]
12. Transplantation of human hematopoietic progenitor cells transduced with a retroviral vector containing the human multidrug-resistance-1 gene for myeloprotective gene therapy.
Laufs S; Baum C; Fruehauf S
Transplant Proc; 2002 Sep; 34(6):2325-9. PubMed ID: 12270418
[No Abstract] [Full Text] [Related]
13. In vitro models of multiple drug resistance.
Greenberger LM; Cohen D; Horwitz SB
Cancer Treat Res; 1994; 73():69-106. PubMed ID: 7710911
[No Abstract] [Full Text] [Related]
14. Unanswered questions about multidrug resistance.
Beck WT
Cytotechnology; 1996; 19(3):177-9. PubMed ID: 8862003
[No Abstract] [Full Text] [Related]
15. Genetic therapy using bone marrow transplantation.
Giles RE; Hanania EG; Fu S; Deisseroth A
Cancer Treat Res; 1995; 76():271-80. PubMed ID: 7577339
[No Abstract] [Full Text] [Related]
16. P-glycoprotein and multidrug resistance.
Gottesman MM; Pastan I; Ambudkar SV
Curr Opin Genet Dev; 1996 Oct; 6(5):610-7. PubMed ID: 8939727
[TBL] [Abstract][Full Text] [Related]
17. In vivo models of P-glycoprotein-mediated multidrug resistance.
Gottesman MM; Mickisch GH; Pastan I
Cancer Treat Res; 1994; 73():107-28. PubMed ID: 7710902
[No Abstract] [Full Text] [Related]
18. Multidrug resistance is more than MDR1 activity.
Preisler HD
Leuk Res; 1995 Jul; 19(7):429-31. PubMed ID: 7637388
[No Abstract] [Full Text] [Related]
19. 1st International Conference on Reversal of Multidrug Resistance in Cancer. St. Gallen, Switzerland, 1-3 September 1994.
Hamblin TJ
Leuk Res; 1995 Jun; 19(6):427-8. PubMed ID: 7596156
[No Abstract] [Full Text] [Related]
20. [Mechanism of resistance to antitumor agents--its involvement in blood-brain barrier].
Tsuruo T
Yakugaku Zasshi; 1995 Jul; 115(7):513-22. PubMed ID: 7562398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
